Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial

Enriqueta Felip, Nasser Khaled Altorki, Caicun Zhou et al. · The Lancet · 2021

Cited by 1,486 works. doi:10.1016/s0140-6736(21)02098-5

Authors

References